(Q37594356)

21 August 2017

Germline CDH1 mutations in bilateral lobular carcinoma in situ (English)

1 reference

21 August 2017

1 reference

11

1 reference

21 August 2017

8

S E Pinder

1 reference

21 August 2017

10

I Tomlinson

1 reference

21 August 2017

14

E J Sawyer

1 reference

21 August 2017

C Petridis

1

1 reference

21 August 2017

I Shinomiya

2

1 reference

21 August 2017

K Kohut

3

1 reference

21 August 2017

P Gorman

4

1 reference

21 August 2017

M Caneppele

5

1 reference

21 August 2017

V Shah

6

1 reference

21 August 2017

M Troy

7

1 reference

21 August 2017

A Hanby

9

1 reference

21 August 2017

R Roylance

12

1 reference

21 August 2017

M A Simpson

13

1 reference

21 August 2017

language of work or name

English

0 references

publication date

24 December 2013

1 reference

British Journal of Cancer

21 August 2017

1 reference

21 August 2017

110

1 reference

21 August 2017

1053-1057

1 reference

21 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2013.792

21 August 2017

0 references

cites work

Comprehensive molecular characterization of human colon and rectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

E-cadherin germline mutations in familial gastric cancer.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Screening breast MR imaging in women with a history of lobular carcinoma in situ

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Germline E-cadherin mutations in familial lobular breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929874

The role of MRI in invasive lobular carcinoma

1 September 2018

1 reference

12 December 2020

Relationship between breast histopathology and family history of breast cancer

1 reference

12 December 2020

Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia

1 reference

12 December 2020

Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2013.792

1 reference

21 August 2017

1 reference

21 August 2017

1 reference